Addressing Clinical Challenges in T-Cell Lymphomas Through Biomarker-Driven Therapy

Download All
Gain expert insights into best practices and emerging strategies in therapy for patients with T-cell lymphomas with this dynamic online educational program based on a live webinar. Download slides with all the key data, watch the on-demand webcast, listen to the podcast, and join the conversation around an expert-authored commentary.
Steven M. Horwitz, MD

ClinicalThought

Read this commentary from lymphoma expert Steven M. Horwitz, MD, on the current approach for characterization and management of T-cell lymphomas using biomarkers and targeted therapies.

Steven M. Horwitz, MD Released: October 14, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Daiichi Sankyo, Inc.
Kyowa Kirin, Inc.
Seagen Inc.
Takeda Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue